Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Venclexta
Venclexta
FDA Approves Roche Subsidiary's Treatment for Acute Myeloid Leukemia
Yahoo/Guru Focus
Sat, 11/24/18 - 01:27 pm
Roche
Genentech
Venclexta
FDA
AML
acute myeloid leukemia
Roche and AbbVie Push Towards First-Line CLL Treatment
BioSpace
Thu, 11/1/18 - 11:28 am
Roche
Genentech
AbbVie
clinical trials
Venclexta
Gazyva
CLL
chronic lymphocytic leukemia
AbbVie, Tolero team up to test Venclexta combo in AML
Fierce Biotech
Sat, 08/18/18 - 05:09 pm
AbbVie
Tolero Pharmaceuticals
Venclexta
alvocidib
AML
AbbVie, Roche post a big win with a blockbuster FDA OK for Venclexta/Rituxan combo for leukemia
Endpoints
Mon, 06/11/18 - 09:17 am
AbbVie
Roche
Venclexta
Rituxan
CLL
chronic lymphocytic leukemia
ASCO18: AbbVie blood cancer combo off to a strong start in Phase 2
Biopharma Dive
Mon, 06/4/18 - 09:37 am
AbbVie
Imbruvica
Venclexta
chronic lymphocytic leukemia
small lymphocytic lymphoma
ASCO 2018
AbbVie Makes Progress on Quest to Diversify
Motley Fool
Tue, 12/12/17 - 10:40 pm
AbbVie
biosimilars
Roche
Venclexta
#ASH17: Late breaker from AbbVie, Roche highlights a blockbuster breakout opportunity for Venclexta in CLL
Endpoints
Fri, 11/24/17 - 09:25 am
ASH
AbbVie
Roche
Venclexta
CLL
chronic lymphocytic leukemia
7 Things AbbVie's Top Executives Just Said That You'll Want to Know
Motley Fool
Fri, 11/10/17 - 10:19 am
AbbVie
Humira
Imbruvica
Venclexta
Amazon
tax reform
AbbVie, Roche to seek broader market for leukemia drug after trial success
BioPharma Dive
Tue, 09/19/17 - 10:23 pm
AbbVie
Roche
clinical trials
Venclexta
Rituxan
chronic lymphocytic leukemia
3 Big Pharma Companies With the Best Pipelines
Motley Fool
Sun, 04/9/17 - 12:24 pm
JNJ
Actelion
Darzalex
Novartis
Cosentyx
Jakavi
Lucentis
Tasigna
Roche
Venclexta
Tecentriq
emicizumab
AbbVie Inc: New Drugs May Overcome Humira Loss
Bidness, ETC
Mon, 08/1/16 - 03:56 pm
AbbVie
Humira
Rova-T
Venclexta
Imbruvica
Viekira Pak
Inside AbbVie’s Plans to Target Multiple Myeloma and Acute Myeloid Leukemia Segments with Venclexta
Market Realist
Mon, 07/11/16 - 10:50 am
AbbVie
Multiple Myeloma
acute myeloid leukemia
Venclexta
AbbVie wins FDA approval for leukemia drug
BioPharma Dive
Mon, 04/11/16 - 05:22 pm
AbbVie
FDA
Venclexta
CLL
Genentech
Pages
« first
‹ previous
1
2